Comments on: Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer

Comments on: Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer https://9krapalm.com/positive-guidance-from-the-u-s-fda-on-64cu-sar-bispsma-phase-iii-trial-in-patients-with-recurrence-of-prostate-cancer/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Mon, 14 Oct 2024 13:49:39 +0000 hourly 1 https://wordpress.org/?v=7.0